{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:37:04Z","timestamp":1792226224722,"version":"4.4.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7682","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T06:43:11Z","timestamp":1506926591000},"page":"9051-9059","source":"Crossref","is-referenced-by-count":9,"title":["Increased expression of high mobility group box protein 1 and vascular endothelial growth factor in placenta previa"],"prefix":"10.3892","volume":"16","author":[{"given":"Han","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"key":"key20180108005726_b1-mmr-16-06-9051","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG)Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and ManagementRCOG Green-top Guideline No. 27https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/gtg_27.pdfJanuary2011"},{"key":"key20180108005726_b2-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1272\/jnms.75.146","article-title":"Risk factors for peripartum blood transfusion in women with placenta previa: A retrospective analysis","volume":"75","author":"Oya","year":"2008","journal-title":"J Nippon Med Sch"},{"key":"key20180108005726_b3-mmr-16-06-9051","first-page":"430","article-title":"Publications Committee, Society for Maternal-Fetal Medicine and Belfort MA Placenta accreta","volume":"203","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108005726_b4-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: Risk factors and complications","volume":"193","author":"Usta","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108005726_b5-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/plac.2001.0764","article-title":"Placenta accreta-summary of 10 years: A survey of 310 cases","volume":"23","author":"Gielchinsky","year":"2002","journal-title":"Placenta"},{"key":"key20180108005726_b6-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0002-9378(97)70017-6","article-title":"The association of placenta previa with history of cesarean delivery and abortion: A meta analysis","volume":"177","author":"Ananth","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108005726_b7-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"188.e1","DOI":"10.1016\/j.ajog.2012.06.083","article-title":"Abnormal vascular architecture at the placental-maternal interface in placenta increta","volume":"207","author":"Chantraine","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108005726_b8-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1387\/ijdb.082769mk","article-title":"Critical growth factors and signalling pathways controlling human trophoblast invasion","volume":"54","author":"Knofler","year":"2010","journal-title":"Int J Dev Biol"},{"key":"key20180108005726_b9-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/pin.12167","article-title":"High mobility group box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts","volume":"64","author":"Abe","year":"2014","journal-title":"Pathol Int"},{"key":"key20180108005726_b10-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0897.2010.00975.x","article-title":"High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia","volume":"66","author":"Wang","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"key20180108005726_b11-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1387\/ijdb.082769mk","article-title":"Critical growth factors and signalling pathways controlling human trophoblast invasion","volume":"54","author":"Knofler","year":"2010","journal-title":"Int J Dev Biol"},{"key":"key20180108005726_b12-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108005726_b13-mmr-16-06-9051","unstructured":"SiuMKChanHYKongDSWongESWongOGNganHYTamKFZhangHLiZChanQKp21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patientsProc Natl Acad Sci USA1071862218627201010.1073\/pnas.0907481107209267452972956"},{"key":"key20180108005726_b14-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4149\/neo_2013_064","article-title":"p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1\/2 pathway mediated MMP-2 secretion","volume":"60","author":"Lu","year":"2013","journal-title":"Neoplasma"},{"key":"key20180108005726_b15-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/ajg.2011.231","article-title":"Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease","volume":"106","author":"Vitali","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"key20180108005726_b16-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/onc.2013.459","article-title":"High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A","volume":"33","author":"Nehil","year":"2014","journal-title":"Oncogene"},{"key":"key20180108005726_b17-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12035-013-8533-4","article-title":"HMGB1 contributes to regeneration after spinal cord injury in adult zebrafish","volume":"49","author":"Fang","year":"2014","journal-title":"Mol Neurobiol"},{"key":"key20180108005726_b18-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/MIB.0000000000000113","article-title":"Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease","volume":"20","author":"Palone","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key20180108005726_b19-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-014-0148-4","article-title":"Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats","volume":"15","author":"Yang","year":"2014","journal-title":"Respir Res"},{"key":"key20180108005726_b20-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.4049\/jimmunol.1300938","article-title":"Leukocyte HMGB1 is required for vessel remodeling in regenerating muscles","volume":"192","author":"Campana","year":"2014","journal-title":"J Immunol"},{"key":"key20180108005726_b21-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/humrep\/det461","article-title":"High mobility group box 1 (HMGB1) protein in human uterine fluid and its relevance in implantation","volume":"29","author":"Bhutada","year":"2014","journal-title":"Hum Reprod"},{"key":"key20180108005726_b22-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/aji.12274","article-title":"Circulating cytokines and alarmins associated with placental inflammation in high-risk pregnancies","volume":"72","author":"Girard","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"key20180108005726_b23-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.176.1.12","article-title":"Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine","volume":"176","author":"Mitola","year":"2006","journal-title":"J Immunol"},{"key":"key20180108005726_b24-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3349\/ymj.2014.55.5.1165","article-title":"The role of high mobility group box 1 in innate immunity","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med J"},{"key":"key20180108005726_b25-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1083\/jcb.152.6.1197","article-title":"The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells","volume":"152","author":"Degryse","year":"2001","journal-title":"J Cell Biol"},{"key":"key20180108005726_b26-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000153188.68898.ac","article-title":"Innate immunity and angiogenesis","volume":"96","author":"Frantz","year":"2005","journal-title":"Circ Res"},{"key":"key20180108005726_b27-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9440(10)62344-9","article-title":"Angiogenetic signaling through hypoxia: HMGB1: An angiogenetic switch molecule","volume":"166","author":"Schlueter","year":"2005","journal-title":"Am J Pathol"},{"key":"key20180108005726_b28-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/db09-1507","article-title":"High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism","volume":"59","author":"Biscetti","year":"2010","journal-title":"Diabetes"},{"key":"key20180108005726_b29-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2478\/v10042-009-0024-0","article-title":"Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy","volume":"47","author":"Naumnik","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"key20180108005726_b30-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12253-012-9539-3","article-title":"The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma","volume":"18","author":"Chuangui","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"key20180108005726_b31-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2567.2007.02662.x","article-title":"The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta","volume":"122","author":"Holmlund","year":"2007","journal-title":"Immunology"},{"key":"key20180108005726_b32-mmr-16-06-9051","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.placenta.2004.12.011","article-title":"Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placentaaccreta","volume":"27","author":"Tseng","year":"2006","journal-title":"Placenta"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:58:09Z","timestamp":1515376689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,10,2]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7682"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7682","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]}}}